Hemofiltration Successfully Eliminates Severe Cytokine Release Syndrome Following CD19 CAR-T-Cell Therapy

Cytokine release syndrome (CRS) remains to be a major adverse effect of chimeric antigen receptor T (CAR-T) cell therapy in B-cell acute lymphoblastic leukemia (B-ALL) and lymphoma. It was urgent to explore novel strategy for managing severe CRS. We conducted a clinical trial to assess the safety an...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yanfen, Chen, Xinfeng, Wang, Dao, Li, Hong, Huang, Jianmin, Zhang, Zhen, Qiao, Yingjin, Zhang, Hongling, Zeng, Ying, Tang, Chao, Yang, Shuangning, Wan, Xiaochun, Chen, Youhai H., Zhang, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2018
Materias:
Clinical Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200371/
https://www.ncbi.nlm.nih.gov/pubmed/30198955
http://dx.doi.org/10.1097/CJI.0000000000000243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200371/
https://www.ncbi.nlm.nih.gov/pubmed/30198955
http://dx.doi.org/10.1097/CJI.0000000000000243

Ejemplares similares